BioCentury
ARTICLE | Company News

Boston Oncology LLC, Oncobiologics deal

November 12, 2012 8:00 AM UTC

Boston Oncology received rights in the Middle East and North African regions to develop and commercialize four undisclosed biosimilars to treat cancer and immunological diseases from Oncobiologics. On...